The 20 Best Inflammatory Myofibroblastic Tumor Doctors Near Me in New York, NY

Dr. Henick is a medical oncologist specializing in the care of patients with malignancies of the aerodigestive tract. As the Director of the HICCC Phase I Unit and Director of Translational Research in Aerodigestive Cancers in Medical Oncology, Dr. Henick’s clinical care and research are aligned to improve the effectiveness of, and limit side effects from, emerging cancer treatments. These efforts entail clinical trials that Dr. Henick has written and leads to study novel therapeutic approaches and to reduce steroid dependence among patients experiencing adverse events from immunotherapy. Dr. Henick is rated as an Experienced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Small Cell Lung Cancer (SCLC), and Squamous Cell Lung Carcinoma. Dr. Henick is board certified in Internal Medicine. Dr. Henick is currently accepting new patients.

Vamsidhar Velcheti is an Oncologist practicing medicine in New York, New York. Dr. Velcheti is rated as an Advanced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), and Bone Marrow Aspiration.

I am a board-certified medical oncologist specializing in the treatment of thoracic malignancies. I received my undergraduate degree from Princeton University, an MD from the combined Harvard Medical School and MIT Program in Health Sciences and Technology (HST), and an MSc in the History of Science and Medicine from Imperial College, London. I completed my internship and residency training in internal medicine at Massachusetts General Hospital, where I was a Stanbury Physician-Scientist trainee, and my fellowship in medical oncology at Memorial Sloan-Kettering Cancer Center, where I was Chief Fellow. I see patients with all types of thoracic malignancies, including non-small cell lung cancer, small cell lung cancer, mesothelioma and thymoma. As someone whose own life was touched by cancer diagnoses, I work with a team of specialists to bring individual, compassionate care to each of my patients.  My research interests are in lung cancer and cancers with special difficulties repairing damage to their DNA. I develop clinical trials using novel agents targeting DNA repair, bringing these drugs directly to my patients in the clinic. My laboratory work aims to define new vulnerabilities in cancer cells which can be leveraged for more effective, less toxic therapy. This work has been recognized by several awards from the NIH and other organizations. Dr. Herzberg is rated as an Experienced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Pleuropulmonary Blastoma, Non-Small Cell Lung Cancer (NSCLC), and Small Cell Lung Cancer (SCLC). Dr. Herzberg is board certified in Medical Oncology. Dr. Herzberg is currently accepting new patients.

Dr. Catherine Shu is the Price Family Associate Professor of Medicine and a board-certified medical oncologist specializing in the treatment of thoracic cancers, with a focus on lung cancer. She received her undergraduate degree from Princeton University, followed by her M.D. from Columbia University College of Physicians and Surgeons. After residency at Columbia University Medical Center, Dr. Shu completed her fellowship at Memorial Sloan Kettering Cancer Center, where she was appointed Chief Fellow. She currently serves as the Director of the Thoracic Medical Oncology Service. She has presented her work at numerous international conferences and has published in the top peer-reviewed oncology journals. She treats the entire spectrum of lung cancer, and has a particular interest in earlier stage and surgically resectable disease, specifically on drug combinations to help improve survival in this setting. Additionally, she runs the thoracic oncology clinical trial portfolio and devotes part of her research effort to patients with targetable mutations such as EGFR. Of all her achievements, she is proudest to be able to offer individualized and compassionate care to each and every one of her patients. She understands that each patient and family carries forth a different set of beliefs, goals, and needs. Working alongside an exceptional multidisciplinary team, she is dedicated to improving the survival and bettering the quality of life of her patients. Dr. Shu is rated as an Experienced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, EGFR Positive Lung Cancer, Small Cell Lung Cancer (SCLC), and Salpingo-Oophorectomy. Dr. Shu is board certified in Internal Medicine and Medical Oncology. Dr. Shu is currently accepting new patients.

Pradeep Goyal is an Interventional Radiologist practicing medicine in Bronx, New York. Dr. Goyal is rated as an Experienced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. His clinical expertise encompasses Apoplexy, Pituitary Apoplexy, Thoracic Aortic Aneurysm, Inflammatory Myofibroblastic Tumor, and Prostatic Artery Embolization.

Santosh Kumar is a Hematologist practicing medicine in East Syracuse, New York. Dr. Kumar is rated as an Experienced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Anemia, Thrombocytopenia, Familial Colorectal Cancer, Prostatectomy, and Cataract Removal.

Lanyi Chen is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Chen is rated as an Experienced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. She is also highly rated in 1 other condition, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Melanoma, and Inflammatory Myofibroblastic Tumor. Dr. Chen is currently accepting new patients.

David D'adamo is an Oncologist practicing medicine in New York, New York. Dr. D'adamo is rated as an Experienced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Synovial Sarcoma, and Agranulocytosis.

Ping Chi is an Oncologist practicing medicine in New York, New York. Dr. Chi is rated as an Experienced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. She is also highly rated in 20 other conditions, according to our data. Her clinical expertise encompasses Gastrointestinal Stromal Tumor, Malignant Peripheral Nerve Sheath Tumor, Adult Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, and Endoscopy. Dr. Chi is currently accepting new patients.

Alexander Drilon is an Oncologist practicing medicine in New York, New York. Dr. Drilon is rated as an Experienced provider by MediFind in the treatment of Inflammatory Myofibroblastic Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Adenocarcinoma, and EGFR Positive Lung Cancer. Dr. Drilon is currently accepting new patients.